[REGN] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -8.87%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 13,117,200 12,172,900 16,071,700 8,497,100 7,863,400 6,710,800 5,872,227 14.32%
PBT 4,199,300 4,858,800 9,325,800 3,810,400 2,429,100 2,553,500 2,078,511 12.42%
Tax 245,700 520,400 1,250,500 297,200 313,300 109,100 880,000 -19.14%
NP 3,953,600 4,338,400 8,075,300 3,513,200 2,115,800 2,444,400 1,198,511 21.99%
Tax Rate -5.85% -10.71% -13.41% -7.80% -12.90% -4.27% -42.34% -
Total Cost 9,163,600 7,834,500 7,996,400 4,983,900 5,747,600 4,266,400 4,673,716 11.86%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 30.14 35.64 50.25 41.35 26.91 36.42 20.41 6.70%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 37.05 40.51 76.40 32.65 19.38 21.29 11.27 21.92%
EPS Diluted 34.77 38.22 71.97 30.52 18.46 21.29 10.34 22.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.